It all comes down to one thing and one thing only: can CYDY prove (or are they even trying to prove) that Amarex's alleged breach was gross negligence and/or willful misconduct. Short of that, the most CYDY can get is what they paid to Amarex.

Again, based on the highly precarious financial state of CYDY, they may (or may not) be guided by SA to take the money they paid to Amarex rather than risk a long, protracted, difficult road to proving gross negligence or willful misconduct.

Take the emotion out and leave in the rational thought and it make sense that it is a good possibility that "a bird in the hand is worth two in the bush" is the mantra from SA as there is no guarantee that CYDY could win let alone financially withstand months of arguing their point while leronlimab languishes and the value of the company degrades.